Sign in or create an account to add this stock to your watchlist.
About Medidata Solutions (NASDAQ:MDSO)
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
Industry, Sector and Symbol
Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800
Debt
Debt-to-Equity Ratio0.18
Current Ratio1.63
Quick Ratio1.63
Price-To-Earnings
Trailing P/E Ratio88.62
Forward P/E Ratio76.87
P/E Growth3.82
Sales & Book Value
Annual Sales$545.53 million
Price / Sales8.18
Cash Flow$1.5377 per share
Price / Cash48.99
Book Value$8.82 per share
Price / Book8.54
Profitability
EPS (Most Recent Fiscal Year)$0.85
Net Income$44.38 million
Net Margins7.96%
Return on Equity11.36%
Return on Assets5.59%
Miscellaneous
Employees1,680
Outstanding Shares59,220,000
Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions
What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
How were Medidata Solutions' earnings last quarter?
Medidata Solutions (NASDAQ:MDSO) announced its quarterly earnings data on Thursday, April, 19th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.35 by $0.05. The firm earned $149.20 million during the quarter, compared to analysts' expectations of $146.73 million. Medidata Solutions had a net margin of 7.96% and a return on equity of 11.36%. The company's revenue for the quarter was up 16.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.31 earnings per share. View Medidata Solutions' Earnings History.
When is Medidata Solutions' next earnings date?
What price target have analysts set for MDSO?
13 Wall Street analysts have issued twelve-month price targets for Medidata Solutions' shares. Their predictions range from $78.00 to $98.00. On average, they anticipate Medidata Solutions' stock price to reach $85.3077 in the next year. View Analyst Ratings for Medidata Solutions.
Who are some of Medidata Solutions' key competitors?
Some companies that are related to Medidata Solutions include Splunk (SPLK), Check Point Software Technologies (CHKP), Shopify (SHOP), CA Technologies (CA), Citrix Systems (CTXS), Mobileye (MBBYF), Ansys (ANSS), Synopsys (SNPS), Symantec (SYMC), Take-Two Interactive (TTWO), SS&C Technologies (SSNC), Cadence Design Systems (CDNS), Dropbox (DBX), Ubisoft (UBSFY) and Veeva Systems (VEEV).
Who are Medidata Solutions' key executives?
Medidata Solutions' management team includes the folowing people:
- Mr. Tarek A. Sherif, Co-Founder, Chairman and Chief Exec. Officer (Age 56)
- Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 46)
- Dr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 45)
- Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 47)
- Ms. Julie Iskow, Exec. VP of Product Devel. & CTO
Has Medidata Solutions been receiving favorable news coverage?
News articles about MDSO stock have trended somewhat positive on Saturday, Accern Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Medidata Solutions earned a news impact score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 45.18 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are Medidata Solutions' major shareholders?
Medidata Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include Champlain Investment Partners LLC (3.63%), American Century Companies Inc. (2.44%), Global Thematic Partners LLC (2.34%), Disciplined Growth Investors Inc. MN (1.57%), Eagle Asset Management Inc. (1.49%) and Stephens Investment Management Group LLC (1.40%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Eileen Schloss, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.
Which major investors are selling Medidata Solutions stock?
MDSO stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Russell Investments Group Ltd., Global Thematic Partners LLC, Carillon Tower Advisers Inc., PNC Financial Services Group Inc., Millennium Management LLC, Stevens Capital Management LP and Loomis Sayles & Co. L P. Company insiders that have sold Medidata Solutions company stock in the last year include Carlos Dominguez, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions.
Which major investors are buying Medidata Solutions stock?
MDSO stock was purchased by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Echo Street Capital Management LLC, Rockefeller Capital Management L.P., Champlain Investment Partners LLC, Massachusetts Financial Services Co. MA, Zevenbergen Capital Investments LLC, Disciplined Growth Investors Inc. MN and Eaton Vance Management. View Insider Buying and Selling for Medidata Solutions.
How do I buy shares of Medidata Solutions?
Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medidata Solutions' stock price today?
One share of MDSO stock can currently be purchased for approximately $75.33.
How big of a company is Medidata Solutions?
Medidata Solutions has a market capitalization of $4.51 billion and generates $545.53 million in revenue each year. The company earns $44.38 million in net income (profit) each year or $0.85 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.
How can I contact Medidata Solutions?
Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]
MarketBeat Community Rating for Medidata Solutions (MDSO)
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
Medidata Solutions (NASDAQ:MDSO) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for Medidata Solutions in the last 12 months. Their average twelve-month price target is $85.3077, suggesting that the stock has a possible upside of 13.25%. The high price target for MDSO is $98.00 and the low price target for MDSO is $78.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.77 | 2.85 | 2.85 | 2.77 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $85.3077 | $83.3846 | $83.00 | $83.5385 |
| Price Target Upside: | 13.25% upside | 13.51% upside | 27.75% upside | 27.17% upside |
Medidata Solutions (NASDAQ:MDSO) Consensus Price Target History
Medidata Solutions (NASDAQ:MDSO) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
Medidata Solutions (NASDAQ:MDSO) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Medidata Solutions (NASDAQ MDSO) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.70%
Medidata Solutions (NASDAQ MDSO) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/21/2018 | Rouven Bergmann | CFO | Sell | 3,000 | $75.52 | $226,560.00 | 84,642 |  |
| 4/25/2018 | Michael I Otner | EVP | Sell | 10,395 | $70.05 | $728,169.75 | 74,165 | |
| 4/19/2018 | Rouven Bergmann | CFO | Sell | 4,000 | $71.50 | $286,000.00 | 93,744 | |
| 3/19/2018 | Rouven Bergmann | CFO | Sell | 2,000 | $66.30 | $132,600.00 | 94,744 | |
| 3/12/2018 | Tarek Sherif | CEO | Sell | 26,836 | $70.25 | $1,885,229.00 | | |
| 2/20/2018 | Rouven Bergmann | CFO | Sell | 2,000 | $67.47 | $134,940.00 | 82,775 | |
| 1/24/2018 | Rouven Bergmann | CFO | Sell | 3,000 | $70.00 | $210,000.00 | 84,775 | |
| 1/19/2018 | Rouven Bergmann | CFO | Sell | 2,000 | $66.46 | $132,920.00 | 87,775 | |
| 12/19/2017 | Rouven Bergmann | CFO | Sell | 2,000 | $65.95 | $131,900.00 | 89,775 | |
| 11/30/2017 | Carlos Dominguez | Director | Sell | 9,066 | $66.85 | $606,062.10 | 66,020 | |
| 11/30/2017 | Rouven Bergmann | CFO | Sell | 2,000 | $65.40 | $130,800.00 | 91,775 | |
| 11/17/2017 | Michael Pray | EVP | Sell | 5,944 | $70.47 | $418,873.68 | | |
| 11/15/2017 | Michael L Capone | COO | Sell | 5,000 | $66.33 | $331,650.00 | | |
| 11/6/2017 | Robert Taylor | Director | Sell | 5,000 | $71.39 | $356,950.00 | 49,372 | |
| 11/2/2017 | Michael I Otner | EVP | Sell | 10,000 | $70.88 | $708,800.00 | 80,674 | |
| 11/2/2017 | Tarek Sherif | CEO | Sell | 200,000 | $68.76 | $13,752,000.00 | | |
| 8/15/2017 | Michael L. Capone | COO | Sell | 5,000 | $74.53 | $372,650.00 | | |
| 6/5/2017 | Robert Taylor | Director | Sell | 5,639 | $73.46 | $414,240.94 | 54,372 | |
| 5/15/2017 | Michael L Capone | COO | Sell | 5,000 | $69.46 | $347,300.00 | 171,754 | |
| 5/1/2017 | Michael I Otner | EVP | Sell | 7,500 | $66.39 | $497,925.00 | 78,419 | |
| 4/4/2017 | Tarek Sherif | CEO | Sell | 2,964 | $57.08 | $169,185.12 | 815,356 | |
| 3/9/2017 | Vries Glen Michael De | President | Sell | 7,500 | $56.05 | $420,375.00 | 934,929 | |
| 3/2/2017 | Tarek Sherif | CEO | Sell | 7,500 | $57.06 | $427,950.00 | 825,820 | |
| 2/14/2017 | Michael L. Capone | COO | Sell | 5,000 | $56.14 | $280,700.00 | | |
| 1/25/2017 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $50.83 | $508,300.00 | | |
| 1/11/2017 | Vries Glen Michael De | President | Sell | 7,500 | $52.44 | $393,300.00 | | |
| 1/4/2017 | Tarek Sherif | CEO | Sell | 7,500 | $51.56 | $386,700.00 | | |
| 12/21/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $51.02 | $510,200.00 | 40,400 | |
| 12/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $52.68 | $395,100.00 | 807,080 | |
| 11/30/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $54.87 | $548,700.00 | 50,400 | |
| 11/16/2016 | Eileen Schloss | EVP | Sell | 3,831 | $56.60 | $216,834.60 | 33,561 | |
| 11/16/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 156 | $57.85 | $9,024.60 | 60,556 | |
| 11/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $50.85 | $381,375.00 | 939,017 | |
| 11/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $46.70 | $350,250.00 | 814,580 | |
| 10/26/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $48.50 | $485,000.00 | 60,400 | |
| 10/25/2016 | Michael I Otner | EVP | Sell | 7,331 | $53.87 | $394,920.97 | 86,378 | |
| 10/11/2016 | Vries Glen Michael De | President | Sell | 7,500 | $54.72 | $410,400.00 | 942,653 | |
| 10/4/2016 | Tarek Sherif | CEO | Sell | 7,500 | $54.86 | $411,450.00 | 829,580 | |
| 9/28/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $56.17 | $561,700.00 | 70,400 | |
| 9/12/2016 | Vries Glen Michael De | President | Sell | 7,500 | $53.70 | $402,750.00 | 950,153 | |
| 9/7/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $55.85 | $558,500.00 | 90,400 | |
| 9/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $54.33 | $407,475.00 | 837,580 | |
| 8/31/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $54.11 | $541,100.00 | | |
| 8/29/2016 | Michael I Otner | EVP | Sell | 6,006 | $53.92 | $323,843.52 | 93,709 | |
| 8/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $54.39 | $407,925.00 | 982,653 | |
| 8/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $52.97 | $397,275.00 | 870,080 | |
| 7/29/2016 | Eileen Schloss | EVP | Sell | 2,083 | $53.04 | $110,482.32 | 29,013 | |
| 7/27/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $52.77 | $527,700.00 | 90,400 | |
| 7/26/2016 | Eileen Schloss | EVP | Sell | 10,644 | $52.82 | $562,216.08 | 25,765 | |
| 7/22/2016 | Michael I. Otner | EVP | Sell | 7,500 | $51.27 | $384,525.00 | | |
| 7/20/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 20,825 | $52.89 | $1,101,434.25 | 111,225 | |
| 7/12/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $49.85 | $498,500.00 | 110,400 | |
| 7/12/2016 | Tarek Sherif | CEO | Sell | 22,036 | $49.24 | $1,085,052.64 | 877,580 | |
| 7/12/2016 | Vries Glen Michael De | President | Sell | 32,500 | $49.25 | $1,600,625.00 | 1,015,153 | |
| 7/5/2016 | Tarek Sherif | CEO | Sell | 7,500 | $46.35 | $347,625.00 | | |
| 6/29/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $45.66 | $456,600.00 | 100,166 | |
| 6/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $47.66 | $357,450.00 | 1,022,453 | |
| 6/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $45.90 | $344,250.00 | 906,849 | |
| 5/31/2016 | Robert Taylor | Director | Sell | 3,752 | $45.03 | $168,952.56 | 50,742 | |
| 5/25/2016 | Neil M Kurtz | Director | Sell | 5,937 | $44.95 | $266,868.15 | 110,762 | |
| 5/25/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $44.94 | $449,400.00 | 110,166 | |
| 5/25/2016 | Tarek Sherif | CEO | Sell | 7,500 | $45.00 | $337,500.00 | 914,349 | |
| 4/27/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $45.09 | $450,900.00 | 125,867 | |
| 4/25/2016 | Eileen Schloss | EVP | Sell | 68,717 | $46.53 | $3,197,402.01 | 22,361 | |
| 4/25/2016 | Vries Glen Michael De | President | Sell | 7,500 | $46.36 | $347,700.00 | 1,086,425 | |
| 2/16/2016 | Lee Shapiro | Director | Buy | 1,500 | $33.45 | $50,175.00 | 30,131 | |
| 7/21/2015 | Steven Isaac Hirschfeld | Insider | Sell | 5,293 | $61.00 | $322,873.00 | | |
| 7/20/2015 | Steven Isaac Hirschfeld | Insider | Sell | 4,908 | $59.00 | $289,572.00 | | |
| 5/29/2015 | Eileen Schloss | EVP | Sell | 2,084 | $57.10 | $118,996.40 | | |
| 5/29/2015 | Robert Taylor | Director | Sell | 5,048 | $56.81 | $286,776.88 | | |
| 5/14/2015 | Steven Isaac Hirschfeld | Insider | Sell | 22,153 | $53.36 | $1,182,084.08 | | |
| 4/29/2015 | Eileen Schloss | EVP | Sell | 4,166 | $55.20 | $229,963.20 | | |
| 4/28/2015 | Cory Douglas | CFO | Sell | 12,333 | $55.29 | $681,891.57 | | |
| 3/23/2015 | Vries Glen Michael De | President | Sell | 20,000 | $49.89 | $997,800.00 | | |
| 2/18/2015 | Eileen Schloss | EVP | Sell | 12,065 | $46.98 | $566,813.70 | | |
| 2/17/2015 | Michael I Otner | EVP | Sell | 11,010 | $46.75 | $514,717.50 | | |
| 2/10/2015 | Bryan Charles Spielman | EVP | Sell | 5,851 | $45.00 | $263,295.00 | | |
| 2/10/2015 | Robert Taylor | Director | Sell | 28,672 | $44.07 | $1,263,575.04 | | |
| 2/9/2015 | Cory Douglas | CFO | Sell | 38,000 | $44.24 | $1,681,120.00 | | |
| 2/9/2015 | Eileen Schloss | EVP | Sell | 12,499 | $44.43 | $555,330.57 | | |
| 12/4/2014 | Steven Isaac Hirschfeld | Insider | Sell | 22,075 | $42.53 | $938,849.75 | | |
| 11/19/2014 | Michael L Capone | COO | Buy | 2,400 | $40.01 | $96,024.00 | | |
| 10/3/2014 | Tarek Sherif | CEO | Sell | 20,000 | $45.30 | $906,000.00 | | |
| 9/9/2014 | Vries Glen Michael De | President | Sell | 20,000 | $48.51 | $970,200.00 | | |
| 8/26/2014 | Bryan Charles Spielman | EVP | Sell | 20,000 | $47.73 | $954,600.00 | | |
| 8/22/2014 | Steven Isaac Hirschfeld | EVP | Sell | 23,801 | $44.00 | $1,047,244.00 | | |
| 8/7/2014 | Michael I Otner | EVP | Sell | 10,000 | $44.84 | $448,400.00 | | |
| 8/5/2014 | Tarek Sherif | CEO | Sell | 20,000 | $44.81 | $896,200.00 | | |
| 8/4/2014 | Bryan Charles Spielman | EVP | Sell | 2,261 | $45.00 | $101,745.00 | | |
| 7/8/2014 | Vries Glen Michael De | President | Sell | 20,000 | $40.13 | $802,600.00 | | |
| 7/7/2014 | Tarek Sherif | CEO | Sell | 20,000 | $43.20 | $864,000.00 | | |
| 6/17/2014 | Tarek Sherif | CEO | Sell | 19,818 | $40.27 | $798,070.86 | | |
| 6/17/2014 | Vries Glen Michael De | President | Sell | 20,000 | $40.26 | $805,200.00 | | |
| 4/8/2014 | Vries Glen Michael De | President | Sell | 20,000 | $47.71 | $954,200.00 | 1,077,574 | |
| 4/3/2014 | Tarek Sherif | CEO | Sell | 20,000 | $55.05 | $1,101,000.00 | 920,626 | |
| 2/19/2014 | Eileen Schloss | EVP | Sell | 16,847 | $60.76 | $1,023,623.72 | 45,363 | |
| 2/18/2014 | Steven Isaac Hirschfeld | EVP | Sell | 17,000 | $60.03 | $1,020,510.00 | 108,238 | |
| 2/11/2014 | Vries Glen Michael De | President | Sell | 20,000 | $54.40 | $1,088,000.00 | 1,156,970 | |
| 1/14/2014 | Vries Glen Michael De | President | Sell | 20,000 | $59.35 | $1,187,000.00 | 972,666 | |
| 1/6/2014 | Tarek Sherif | CEO | Sell | 20,000 | $59.44 | $1,188,800.00 | 812,718 | |
| 12/13/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,000 | $113.01 | $1,130,100.00 | 38,451 | |
| 12/11/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,000 | $116.59 | $1,165,900.00 | 38,451 | |
| 12/10/2013 | Vries Glen Michael De | President | Sell | 10,000 | $116.39 | $1,163,900.00 | 517,459 | |
| 12/6/2013 | Tarek Sherif | CEO | Sell | 53,290 | $118.08 | $6,292,483.20 | 437,485 | |
| 12/6/2013 | Vries Glen Michael De | President | Sell | 43,289 | $118.11 | $5,112,863.79 | 528,659 | |
| 11/12/2013 | Cory Douglas | CFO | Sell | 10,000 | $108.08 | $1,080,800.00 | 39,293 | |
| 11/1/2013 | Cory Douglas | CFO | Sell | 30,000 | $109.59 | $3,287,700.00 | | |
| 10/29/2013 | Eileen Schloss | EVP | Sell | 12,500 | $116.08 | $1,451,000.00 | | |
| 10/28/2013 | Lee Shapiro | Director | Sell | 3,800 | $117.48 | $446,424.00 | | |
| 10/28/2013 | Michael I Otner | EVP | Sell | 5,071 | $117.45 | $595,588.95 | | |
| 9/16/2013 | Bryan Charles Spielman | EVP | Sell | 3,905 | $99.47 | $388,430.35 | 19,171 | |
| 8/1/2013 | Michael I Otner | EVP | Sell | 2,500 | $92.16 | $230,400.00 | | |
| 7/26/2013 | Vries Glen Michael De | President | Sell | 56,547 | $90.08 | $5,093,753.76 | | |
| 7/25/2013 | Bryan Charles Spielman | EVP | Sell | 4,145 | $86.66 | $359,205.70 | | |
| 7/1/2013 | Bryan Charles Spielman | EVP | Sell | 3,950 | $78.78 | $311,181.00 | | |
| 6/28/2013 | Steven Isaac Hirschfeld | EVP | Sell | 5,486 | $76.84 | $421,544.24 | | |
| 6/5/2013 | Steven Isaac Hirschfeld | EVP | Sell | 5,189 | $68.84 | $357,210.76 | | |
| 5/22/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,711 | $67.60 | $724,063.60 | | |
| 5/10/2013 | Robert Taylor | Director | Sell | 4,533 | $70.31 | $318,715.23 | | |
| 5/1/2013 | Neil M Kurtz | Director | Sell | 5,910 | $66.02 | $390,178.20 | | |
| 2/25/2013 | Lineene Norris Krasnow | EVP | Sell | 18,690 | $50.39 | $941,789.10 | | |
| 2/22/2013 | Vries Glen Michael De | President | Sell | 56,547 | $50.20 | $2,838,659.40 | | |
| 10/4/2012 | Tarek Sherif | CEO | Sell | 40,000 | $39.47 | $1,578,800.00 | | |
| 10/3/2012 | Vries Glen Michael De | President | Sell | 27,604 | $39.77 | $1,097,811.08 | | |
(Data available from 1/1/2013 forward)
Medidata Solutions (NASDAQ MDSO) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Insider Selling: Medidata Solutions (MDSO) CFO Sells 3,000 Shares of Stock
www.americanbankingnews.com - May 23 at 7:52 PM |
| Medidata Solutions (MDSO) PT Raised to $98.00 at Piper Jaffray Companies
www.americanbankingnews.com - May 23 at 4:19 PM |
 | Morgan Stanley Downgrades Medidata Solutions (MDSO) to Equalweight
www.streetinsider.com - May 23 at 8:54 AM |
 | Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata's eClinical Platform
finance.yahoo.com - May 23 at 8:54 AM |
| Medidata Solutions (MDSO) Expected to Announce Quarterly Sales of $156.27 Million
www.americanbankingnews.com - May 22 at 4:24 AM |
| Medidata Solutions (MDSO) Cut to Hold at Morgan Stanley
www.americanbankingnews.com - May 21 at 11:05 AM |
 | Medidata Solutions -1.3% on analyst downgrade
seekingalpha.com - May 21 at 8:56 AM |
| Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation
finance.yahoo.com - May 21 at 8:56 AM |
| Brokerages Anticipate Medidata Solutions (MDSO) to Announce $0.40 EPS
www.americanbankingnews.com - May 20 at 7:25 AM |
| Should You Be Tempted To Sell Medidata Solutions Inc (NASDAQ:MDSO) At Its Current PE Ratio?
finance.yahoo.com - May 19 at 8:56 AM |
| Medidata Solutions (MDSO) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 17 at 3:31 PM |
| PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone
finance.yahoo.com - May 17 at 9:16 AM |
| Dougherty & Co Reaffirms "Buy" Rating for Medidata Solutions (MDSO)
www.americanbankingnews.com - May 10 at 5:58 PM |
| Medidata to Present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference
finance.yahoo.com - May 10 at 9:17 AM |
| Medidata Solutions (MDSO) Upgraded to "Buy" by BidaskClub
www.americanbankingnews.com - May 5 at 12:11 AM |
| Medidata’s Melinda Pautsch Named a “Rising Star” by the Healthcare Businesswomen’s Association
finance.yahoo.com - May 4 at 9:00 AM |
| Medidata to Present at Jefferies 2018 Global Technology Conference
finance.yahoo.com - May 3 at 9:01 AM |
| Analysts Expect Medidata Solutions (MDSO) to Post $0.40 Earnings Per Share
www.americanbankingnews.com - May 2 at 7:12 PM |
 | Global eClinical Solutions Market to 2024: Market to Grow at a CAGR of 11.9% - Key Players are Medidata Solutions, Oracle, Bioclinica, CRF Health, Merge Healthcare
www.prnewswire.com - May 1 at 8:28 PM |
| Medidata Solutions (MDSO) EVP Michael I. Otner Sells 10,395 Shares
www.americanbankingnews.com - April 27 at 7:08 PM |
| Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018
finance.yahoo.com - April 27 at 9:33 AM |
| Medidata Solutions (MDSO) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 26 at 10:08 AM |
| FY2018 Earnings Forecast for Medidata Solutions Issued By Dougherty & Co (MDSO)
www.americanbankingnews.com - April 25 at 9:34 AM |
| Equities Analysts Offer Predictions for Medidata Solutions' Q2 2018 Earnings (MDSO)
www.americanbankingnews.com - April 24 at 7:54 AM |
| Medidata Solutions (MDSO) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 22 at 3:29 PM |
| Medidata Solutions (MDSO) CFO Sells $286,000.00 in Stock
www.americanbankingnews.com - April 20 at 7:40 PM |
| Medidata Solutions (MDSO) Price Target Raised to $80.00
www.americanbankingnews.com - April 20 at 11:32 AM |
| Is Medidata Solutions Inc (NASDAQ:MDSO) Undervalued?
finance.yahoo.com - April 19 at 4:56 PM |
| Medidata Solutions (MDSO) Releases Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - April 19 at 9:11 AM |
 | Medidata Reaffirms 2018 Outlook - Quick Facts
www.nasdaq.com - April 19 at 9:03 AM |
| Medidata Solutions beats by $0.05, beats on revenue
seekingalpha.com - April 19 at 9:03 AM |
| Medidata Reports First Quarter 2018 Results
finance.yahoo.com - April 19 at 9:03 AM |
| Medidata: 1Q Earnings Snapshot
finance.yahoo.com - April 19 at 9:03 AM |
| Medidata Solutions (MDSO) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 17 at 8:17 AM |
| Medidata Solutions (MDSO) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - April 17 at 3:28 AM |
| Analysts Anticipate Medidata Solutions (MDSO) Will Announce Quarterly Sales of $147.63 Million
www.americanbankingnews.com - April 17 at 2:38 AM |
| Medidata Solutions (MDSO) Downgraded by BidaskClub to "Hold"
www.americanbankingnews.com - April 16 at 8:06 PM |
| Zacks: Brokerages Expect Medidata Solutions (MDSO) to Announce $0.35 EPS
www.americanbankingnews.com - April 15 at 7:17 PM |
| Cross-Selling Can Drive Meaningful Growth For Medidata Solutions
seekingalpha.com - April 13 at 4:48 PM |
| Medidata Solutions (MDSO) Upgraded to "Hold" at ValuEngine
www.americanbankingnews.com - April 12 at 10:18 PM |
| Medidata Solutions (MDSO) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 10:19 AM |
| Medidata Solutions (MDSO) Earns Hold Rating from Jefferies Group
www.americanbankingnews.com - April 9 at 11:59 PM |
 | Medidata Schedules First Quarter Earnings Conference Call for April 19, 2018
www.businesswire.com - April 6 at 9:24 AM |
| Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research
finance.yahoo.com - April 4 at 9:12 AM |
| Zacks Investment Research Lowers Medidata Solutions (MDSO) to Sell
www.americanbankingnews.com - April 2 at 10:44 AM |
| Medidata Solutions (MDSO) Research Coverage Started at Dougherty & Co
www.americanbankingnews.com - April 1 at 11:58 PM |
| Medidata Solutions (MDSO) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 31 at 4:56 PM |
| Zacks: Brokerages Anticipate Medidata Solutions Inc (MDSO) to Post $0.35 Earnings Per Share
www.americanbankingnews.com - March 29 at 9:14 PM |
| Medidata Solutions Inc (MDSO) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 28 at 3:32 PM |
| Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
finance.yahoo.com - March 28 at 9:19 AM |
Medidata Solutions (NASDAQ:MDSO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Medidata Solutions (NASDAQ:MDSO) Income Statement, Balance Sheet and Cash Flow Statement
Medidata Solutions (NASDAQ MDSO) Stock Chart for Saturday, May, 26, 2018
Loading chart…
